课题基金 / 基金详情

Clinical epidemiology and analysis of pathomechanisms of optic-spinal form of multiple sclerosis

Clinical epidemiology and analysis of pathomechanisms of optic-spinal form of multiple sclerosis
视脊髓型多发性硬化症的临床流行病学及发病机制分析
批准号:
09470150
负责人:
ITOYAMA Yasuto
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

ITOYAMA Yasuto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We studied clinical features and pathomechanisms of multiple sclerosis (MS) in Japan, especially optic-spinal form of MS (OSMS). (l)Eighty six cases of MS whose onset of disease were during 1970-1998 were clinically classified. Frequency of cases of MS with acute transverse myelitis (ATM) decreased in 1980s and 1990s compared with 1970s. In contrast, OSMS without ATM and conventinal MS increased in 1 980s. Changes of environmental factors might have caused these changes of clinical picture of MS in Japan. Brainstem and cerebellar symptoms and signs and MRI findings were analyzed in 66 consecutive cases of MS, and 65% had those symptoms and signs. Cerebellarsigns were seen in 30%. Moreover, cerebellar lesions on MRI were seen in only 6.4%, which was significantly lower than the figures in Western countries (50-90%). (2)4-aminopyridine (4-AP) relieves conductionlock in demyelinated nerves by blocking K channels. 4-AP was administered intravenously and motor evoked potentials (MEP) were recorded before and after 4-AP therapy. After 4-AP therapy, MEP amplitudes increased significantly and mean consecutive difference of MEP latency decreased significantly. 4-AP probably caused coordinated contraction of more muscle fibers. (3) Parvovirus 819 (B19) infection is associated with autoimmunity. B19 antibodies in sera and cerebrospinal fluid (CSF) and B19 DNA in CSF were studied in 46 MS patients. Frequency of B19 lgG in MS (65%) was significantly higher than that in controls (40%), but serum 819 lgM and B19 DNA in CSF were consistently negative in excerbation of MS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fujihara K.: "The effects of 4-aminopvridine on motor evoked potentials in multiple sclerosis" J Neurol Sci.vol 159. 102-106 (1998)
Fujihara K.:“4-氨基吡啶对多发性硬化症运动诱发电位的影响”J Neurol Sci.vol 159. 102-106 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
糸山泰人: "多発性硬化症の病因と病態" 日本内科学会雑誌. 87・4. 604-611 (1998)
Yasuto Itoyama:“多发性硬化症的病因学和病理学”日本内科医学会杂志87・4(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakashima I: "Human parvovirus B19 infection in multiple sclerosis" European Neurology. in press.
Nakashima I:“多发性硬化症中的人类细小病毒 B19 感染”欧洲神经病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakashima I.: "Clinical and laboratory features of myelitis patients with anti-neutrophi cytoplasmic antibodies." J Neurol Sci.vol.157. 60-66 (1998)
Nakashima I.:“具有抗中性粒细胞胞浆抗体的脊髓炎患者的临床和实验室特征。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    Establishment of a new disease entity as astrocytopathy, and studies on the pathogenesis and treatment for neuromyelitis optica
    Elucidate the pathomechanism of inclusion body myositis(IBM)
    • 批准号:
      22659167
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.12万
    • 财政年份:
      2010
    • 负责人:
      ITOYAMA Yasuto
    • 依托单位:
    Optic-spinal multiple sclerosis : clarification of pathogenesis, establishment of new disease entity and treatment
    • 批准号:
      19209032
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $26.21万
    • 财政年份:
      2007
    • 负责人:
      ITOYAMA Yasuto
    • 依托单位:
    A Study on the Pathogenesis and Therapy of Optic-Spinal Multiple Sclerosis
    • 批准号:
      17390250
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.09万
    • 财政年份:
      2005
    • 负责人:
      ITOYAMA Yasuto
    • 依托单位:
    海外基金